A Mitochondria-Targeted Macrocyclic Mn(II) Superoxide Dismutase Mimetic  by Kelso, Geoffrey F. et al.
Chemistry & Biology
ArticleA Mitochondria-Targeted Macrocyclic
Mn(II) Superoxide Dismutase Mimetic
Geoffrey F. Kelso,1 Andrej Maroz,2 Helena M. Cocheme´,3,4 Angela Logan,3 Tracy A. Prime,3 Alexander V. Peskin,5
Christine C. Winterbourn,5 Andrew M. James,3 Meredith F. Ross,3 Sally Brooker,6 Carolyn M. Porteous,7
Robert F. Anderson,2 Michael P. Murphy,3,* and Robin A.J. Smith1
1Centre for Green Chemistry, Monash University, Victoria 3800, Australia
2School of Chemical Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
3Medical Research Council Mitochondrial Biology Unit, Hills Road, Cambridge CB2 0XY, UK
4Department of Genetics, Evolution, and Environment, Institute of Healthy Ageing, University College London, Gower Street,
London WC1E 6BT, UK
5Department of Pathology, University of Otago Christchurch, P.O. Box 4345, Christchurch, New Zealand
6Department of Chemistry
7Department of Biochemistry
University of Otago, PO Box 56, Dunedin 9054, New Zealand
*Correspondence: mpm@mrc-mbu.cam.ac.uk
http://dx.doi.org/10.1016/j.chembiol.2012.08.005SUMMARY
Superoxide (O2
,-) is the proximal mitochondrial
reactive oxygen species underlying pathology and
redox signaling. This central role prioritizes develop-
ment of a mitochondria-targeted reagent selective
for controlling O2
,-. We have conjugated a mitochon-
dria-targeting triphenylphosphonium (TPP) cation to
a O2
,--selective pentaaza macrocyclic Mn(II) super-
oxide dismutase (SOD) mimetic to make MitoSOD,
a mitochondria-targeted SOD mimetic. MitoSOD
showed rapid and extensive membrane potential-
dependent uptake into mitochondria without loss
of Mn and retained SOD activity. Pulse radiolysis
measurements confirmed that MitoSOD was a
very effective catalytic SOD mimetic. MitoSOD also
catalyzes the ascorbate-dependent reduction of
O2
,-. The combination of mitochondrial uptake and
O2
,- scavenging by MitoSOD decreased inactivation
of the matrix enzyme aconitase caused by O2
,-.
MitoSOD is an effective mitochondria-targeted
macrocyclic SOD mimetic that selectively protects
mitochondria from O2
,- damage.
INTRODUCTION
The mitochondrial respiratory chain is a major source of super-
oxide (O2
,-), which can go on to form other reactive oxygen
species (ROS), such as hydrogen peroxide (H2O2), the hydroxyl
radical (,OH), and peroxynitrite (ONOO-) (Murphy, 2009). The
production of O2
,- and derived ROS leads to oxidative damage
that disrupts mitochondrial function and thereby contributes to
a range of pathologies, including neurodegenerative diseases,
diabetes, and ischemia-reperfusion injury (Finkel, 2005). Mito-
chondrial ROS production is also an important component of
redox signaling (Collins et al., 2012; Murphy, 2009). To protectChemistry & Biology 19, 1237–1against oxidative damage and explore redox signaling path-
ways, mitochondria-targeted antioxidants have been developed
that comprise a lipophilic triphenylphosphonium (TPP) cation
conjugated to an antioxidant moiety (Murphy and Smith, 2007;
Smith et al., 2011). The large lipophilic surface of the TPP cation
enables such compounds to move rapidly through biological
membranes, while their positive charge causes them to be
accumulated several 100-fold inside mitochondria in vivo driven
by the large membrane potential of up to 180 mV (negative
inside) (Ross et al., 2005). This dramatic mitochondrial accumu-
lation makes targeted antioxidants far more protective against
oxidative damage than untargeted equivalents in cultured cells,
in animal models of pathologies, and in human clinical trials
(Gane et al., 2010; Murphy and Smith, 2007, 2010; Snow et al.,
2010). A targeted version of ubiquinone (MitoQ) is the most
extensively studied of these mitochondria-targeted antioxidants
(Kelso et al., 2001; Murphy and Smith, 2007, 2010). Many other
antioxidants have been targeted to mitochondria by conjugation
to the TPP cation, including vitamin E (Smith et al., 1999), plasto-
quinone (Skulachev et al., 2009), Ebselen (Filipovska et al., 2005),
lipoic acid (Brown et al., 2007), nitroxides (Dhanasekaran et al.,
2005; Trnka et al., 2008), and nitrones (Murphy et al., 2003).
The central role of O2
,- in mitochondrial metabolism requires
the development of a mitochondria-targeted antioxidant that is
selective for O2
,-. A number of mitochondria-targeted antioxi-
dants do react with O2
,-. The nitroxide MitoTEMPOL has SOD
activity in vitro but is rapidly reduced to the hydroxylamine within
mitochondria, and thus its protective properties are not attribut-
able to its reactions with O2
,- (Trnka et al., 2008). The related
molecule, incorporating an amide-linked TPP, MitoTEMPO,
also has SOD activity in vitro, as well as protective effects in vivo
(Dikalova et al., 2010); however, its biological activity is unlikely
to be due to its SOD activity as it is also reduced to the hydrox-
ylamine in vivo (Soule et al., 2007). The mitochondria-targeted
nitroxide Mito-Carboxy Proxyl (MitoCP) protects against oxida-
tive damage to mitochondria far more effectively than the untar-
geted version and has a O2
,- dismutation rate of 105 M1 s1
in vitro (Dhanasekaran et al., 2005); however, it is likely that
protection byMitoCP is largely due to other antioxidant reactions246, October 26, 2012 ª2012 Elsevier Ltd All rights reserved 1237
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Figure 1. Synthesis and Structure of MitoSOD
(A) MitoSOD (1) was obtained by Mn(II) template cyclization of the tetraamine
3 and the 2,6-pyridine dialdehyde derivative 4 followed by in situ borohydride
reduction. Compound 4 was obtained from chelidamic acid (5) via the bro-
modiol (6) and oxidized derivatives (7, 8). M40403 (2) was obtained similarly
from 3 and 2,6-pyridine dialdehyde.
(B) A projection view ofMitoSOD [Mn(II)(L+)(Cl)(OH2)](Cl)2$CH3CH2OH (1(OH2)$
CH3CH2OH) derived from single crystal X-ray diffraction data. The dashed
lines represent hydrogen bonds. O(70) and O(80) represent the oxygen atoms
of half occupancy ethanol molecules. O(1) represents the oxygen atom of
a coordinated H2O molecule. Only the major occupancy site of Cl(2) is shown.
Hydrogen atoms, other than those on chiral centers or involved in hydrogen
bonding, have been omitted for clarity.
See also Tables S1–S3.
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MitoSODof this nitroxide and its hydroxylamine reaction products (Kagan
et al., 2007). A TPP-conjugated version of the salen-Mn(III)
compound EUK-134 has only limited protection against oxida-
tive damage; however, its uptake into mitochondria was not
demonstrated (Dessolin et al., 2002). Furthermore, as this class
of Mn(III) complex has both SOD and catalase mimetic activity,1238 Chemistry & Biology 19, 1237–1246, October 26, 2012 ª2012 Eit would be difficult to distinguish the effects of depleting O2
,-
from that of degrading H2O2 (Doctrow et al., 1997).
Although there are a number of antioxidant compounds tar-
geted to mitochondria that do react with O2
,-, they are not
selective, and furthermore their rates of reaction with O2
,- are
typically 105 M1s1, considerably lower than that of MnSOD,
themitochondrial SOD isoform (23 109 M1 s1; Cadenas and
Davies, 2000). As the biological effects of these compounds are
unlikely to be due solely to their reactivity with O2
,-, they cannot
be used to infer the role of mitochondrial O2
,- in oxidative
damage or redox signaling. Consequently, there is a need to
modulate mitochondrial O2
,- selectively using a synthetic mito-
chondria-targeted SOD mimetic. The importance of this chal-
lenge is supported by the observation that selectively decreasing
mitochondrial O2
,- by overexpressing MnSOD enzyme gives
therapeutically relevant protection in animal models of disease
(Chen et al., 1998) and modulates redox signaling (Kim et al.,
2004;Murphy, 2009). To address this need, we have synthesized
a mitochondria-targeted SOD mimetic, MitoSOD (1), based on
the established pentaaza macrocyclic Mn(II) SOD mimetic
M40403 (2) (Salvemini et al., 1999, 2002) (Figure 1A). This mole-
cule was chosen from a wide variety of known Mn-based SOD
mimetics (Batinic-Haberle et al., 2010; Iranzo, 2011) because it
is an effective SOD mimetic in vitro and has been shown to be
stable and protective in vivo (Thompson et al., 2010). Our
previous study of M40403 reaction kinetics using pulse radiol-
ysis demonstrated that in a phosphate environment it catalyzes
O2
,- dismutation to H2O2 with kcat = 3.55 3 10
6 M1 s1 at 22C
(pH 7.4) (Maroz et al., 2008), in good agreement with the value
more recently reported using the stopped flow method (2.3 ±
0.1 3 106 M1s1 [pH 7.4], 21C; Friedel et al., 2012). The cata-
lytic SOD cycle involves an initial fast reaction of M40403 with
O2
,- (k1 = 9.0 ± 0.5 3 10
7 M1 s1, 22C [pH 8.0]) to produce a
[MnIII(L)ClnO2]
(2-n)+ intermediate containing a coordinated
peroxide (Maroz et al., 2008). This rapid reaction underlies the
O2
,- selectivity of M40403 and its lack of reactivity with other
ROS, such as ONOO-, H2O2 or HOCl (Salvemini et al., 2002).
Whereas a triethylenetetraamine analog of M40403 reacts with
NO (Filipovic et al., 2008, 2010), the rate constant is about 105
times smaller than that for the initial reaction of M40403 with
O2
,-. The SOD mimetic Mn(III) metalloporphyrins (Batinic-
Haberle, 2002) have high rates of reaction with O2
,-, but they
are not chemoselective as they also react at comparable rates
with ONOO- and CO3
,- (Salvemini et al., 2002). The Mn(III)-salen
compounds have SOD activity but also show catalase activity
(Doctrow et al., 1997). Here, we report the synthesis of a mito-
chondria-targeted SOD mimetic, MitoSOD, that is accumulated
by mitochondria and selectively degrades mitochondrial O2
,-,
protecting against oxidative damage. The chemical and biolog-
ical properties of MitoSOD establish an opportunity to control
and assess O2
,- production within mitochondria.
RESULTS AND DISCUSSION
Design and Synthesis of MitoSOD
MitoSOD was designed by attaching a TPP lipophilic cation to
the pyridine ring of M40403 so as to drive its selective accu-
mulation and ultimate dismutation of O2
,- within mitochondria.
MitoSOD (1) and the untargeted SOD mimetic macrocyclelsevier Ltd All rights reserved
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Figure 2. Kinetics ofMitoSODActivityMeasured by Pulse Radiolysis
(A) Kinetic plots showing the dependence of the reciprocal first half-life of O2
,-
on the concentration of O2
,- at pH 8.0, measured at 270 nm, in the absence
(control) and with increasing concentrations of MitoSOD. Data were obtained
following the pulse radiolysis (35–100 Gy in 1.5 ms) of oxygen-saturated
aqueous solutions containing sodium formate (10 mM), phosphate buffer
(10 mM), and EDTA (0.1 mM).
(B) Dependence of rate constants for the reaction of MitoSOD with O2
,-
(derived from intercepts of A) on the concentration of MitoSOD. The slope of
the fitted line provides the value for kcat shown in Table 1.
Table 1. Superoxide Dismutase Activity of MitoSOD and M40403
Measured by Pulse Radiolysis
Compound
kcat 3 10
6 (M1 s1)
pH 7.4 pH 8.0
MitoSOD 2.5 ± 0.2 5.3 ± 0.2
M40403 3.6 ± 0.2 2.6 ± 0.2
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MitoSODM40403 (2) were synthesized as shown in Figure 1A, and the
structure of MitoSOD was determined by X-ray crystallography
(Figure 1B). The structure of MitoSOD was similar to that of
M40401, the active dimethyl analog of M40403 (Aston et al.,
2001), and the addition of a TPP cation appendage did not distort
the macrocycle conformation, which is crucial for SOD-mimetic
activity.
Kinetics of Superoxide Dismutation by MitoSOD
To determine whether MitoSOD was an effective SOD mimetic,
we measured its rate of catalytic dismutation of O2
,-. This was
done by generating O2
,- (1–60 mM in 1.5 ms) by the pulse radiol-
ysis of phosphate buffer (pH 7.4 or 8.0), containing sodium
formate and EDTA, and measuring the decay of O2
,- spectro-
photometrically (Bielski et al., 1985). In the absence of MitoSOD,
O2
,- decay followed mixed first- and second-order kinetics,
which is interpreted as the spontaneous dismutation of O2
,- (kself)
and background catalytic decomposition, presumably by trace
metal impurities. When [MitoSOD][ [O2
,-], the decay of O2
,-
was predominantly pseudo-first-order because of the fast reac-
tion of the macrocycle with O2
,- (k1 = 1.57 ± 0.04 3 10
8 M1 s1
[pH 8.0]). We propose that the product of this reaction is
a [MnIII(L-TPP)ClnO2]
(3-n)+ intermediate containing a coordinatedChemistry & Biology 19, 1237–1peroxide, as has been demonstrated for the parent M40403
macrocycle (Maroz et al., 2008). When catalytic (1–6 mM)
amounts of MitoSOD were present at pH 8.0, reflecting that
within mitochondria, the rate of O2
,- decay (20–60 mM) was
considerably faster compared to O2
,- alone and also followed
mixed first- and second-order kinetics, which indicated that
O2
,- was decaying by spontaneous (kself) and MitoSOD-cata-
lyzed (kobs) dismutation. To determine kobs, the first half-life
(t1/2) of O2
,- decaywasmeasured over a range of O2
,- concentra-
tions with different concentrations of MitoSOD, and then plots of
1/t1/2 versus [O2
,-] were constructed (Figure 2A), and values of
kobs were calculated from the y-intercepts, as previously
described (Anderson et al., 2003). A plot of kobs versus MitoSOD
concentration was linear (Figure 2B), demonstrating that the
decay of O2
,- was first order in bothO2
,- andMitoSOD, indicative
of catalytic dismutation. The rate constant for the catalyzed
dismutation (kcat) was calculated from the slope of the fitted
function and is presented in Table 1 along with the value
measured at pH 7.4 and our previously determined values for
M40403 (Maroz et al., 2008). MitoSOD and M40403 were found
to have similar SOD activities, but that of MitoSOD decreased
at pH 7.4 (Table 1), presumably because of a pH-dependent
effect of the (3-mercaptopropyl) triphenylphosphonium substit-
uent on the reactivity of the intermediate Mn(III) complex. In
summary, MitoSOD is an effective SOD mimetic, and its initial
fast reaction with O2
,- underlies the selectivity for this ROS in
a biological environment.
To evaluate whether MitoSOD could also act as a SOD
mimetic under the steady-state O2
,- flux that occurs within
mitochondria, O2
,- was generated continuously by xanthine
oxidase (XO) and monitored by the rate of cytochrome c reduc-
tion. The reactivity of MitoSOD with O2
,- was determined from
its competition with cytochrome c reduction (Figures 3A and
3B) (Loschen et al., 1974). These experiments showed that
MitoSOD effectively blocked cytochrome c reduction in a
dose-dependent manner by competing for O2
,-, whereas a
control TPP cation without any bioactive cargo, methyltriphenyl-
phosphonium bromide (TPMP), was ineffective (Figures 3A and
3B). A plot of the reciprocal of the cytochrome c reduction rate
versus compound concentration from Figure 3B was linear
and, by slope comparison, indicated that 1.1 nmol MitoSOD
corresponded to 1 U Cu, ZnSOD. In a separate approach, we
assessed the ability of MitoSOD to intercept a steady-state
flux of O2
,- using the WST-1 reduction assay (Peskin and
Winterbourn, 2000). Here, we found that to get 50% inhibition
of WST-1 reduction required 2.4 ± 0.1 ng (0.14 pmol) Cu,ZnSOD
monomer; 96 ± 28 ng (197 pmol) M40403; and 10 ± 5 ng
(20 pmol) MitoSOD (means ± SD, n = 3). So by this assay, Mito-
SOD is 10-fold more effective than M40403 and 140-fold
less effective than Cu,ZnSOD.246, October 26, 2012 ª2012 Elsevier Ltd All rights reserved 1239
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Figure 3. Steady-State Activity of MitoSOD
(A) O2
,- was generated by the addition of xanthine
oxidase (XO). Where indicated (second arrow)
MitoSOD (2–15 mM) or control compound (meth-
yltriphenylphosphonium bromide; TPMP, 15 mM)
was added, and the rate of reduction of cyto-
chrome c by O2
,- was assessed at 550 nm. Data
shown are typical traces of experiments repeated
in triplicate.
(B) The slope of cytochrome c reduction by XO/
hypoxanthine in the presence of the indicated
additions was divided by that in the absence of
additions to give the relative SOD activity. Data are
means ± SD, n = 3.
(C) Ascorbate oxidation and cytochrome c reduc-
tion in the presence of M40403 and MitoSOD.
A flux of O2
,- was generated by addition of XO
and acetaldehyde (10 mM), and then Cu,ZnSOD
(60 nM) or various concentrations of M40403 and
MitoSOD were added. Then either cytochrome c
was added and its rate of reduction wasmonitored
at 550 nm, or ascorbate 30 mM was added and
its rate of oxidation was monitored at 266 nm.
Note that MitoSOD has a greater effect on cyto-
chrome c reduction in (C) than in (A) and (B)
because the flux of superoxide generated is about
3-fold lower in (C). Data aremeans ± ranges for 2–3
determinations.
(D) The proposed mechanism for the MitoSOD-
catalyzed dismutation of O2
,- is shown. In addition,
an alternative path for the rate-limiting reduction of
the Mn(III) species to Mn(II) by ascorbate is shown
as a dashed line.
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MitoSODThe Mn(III) porphyrin SOD mimetics were more effective at
protecting against O2
,- within cells than their in vitro SOD activity
would predict (Faulkner et al., 1994). Because SOD catalysis by
M40403 involves a rate-limiting reduction of an intermediate
Mn(III) complex by another O2
,- (Maroz et al., 2008), in a biolog-
ical environment this intermediate could be reduced by reduc-
tants other than O2
,-. The mitochondrial matrix contains a signif-
icant amount of ascorbate (0.5 mM) (Li et al., 2001); therefore,
we indirectly assessed ascorbate reduction of the MitoSOD and
M40403 Mn(III) intermediates by measuring ascorbate oxida-
tion in the presence of SOD mimetic and O2
,- (Figure 3C). As ex-
pected from the rate constant (3 3 105 M1s1) for the direct
reaction of ascorbate with O2
,- (Gotoh and Niki, 1992), when
we generated O2
,- by XO there was rapid oxidation of ascorbate.
However, in contrast to the more catalytically active Cu, Zn SOD
enzyme, neither MitoSOD nor M40403 decreased ascorbate
oxidation (Figure 3C). This result suggests that in the presence
of O2
,-, the Mn(III) intermediate within the catalytic cycle of
MitoSOD or M40403 SOD activity oxidizes ascorbate (Fig-
ure 3D), as the rate constants for the initial reaction of O2
,- with
MitoSOD (k1 = 1.38 ± 0.08 3 10
8 [pH 7.2]) or M40403 (8.9 ±
0.4 3 107 M1 s1 [pH 7.4]) (Maroz et al., 2008) are much higher
than that of O2
,- with ascorbate. Neither GSH nor NADH were
able to accelerate the steady-state dismutation of O2
,- by
MitoSOD when measured as in Figure 3A (data not shown),
suggesting these biological-reducing agents do not react
with the Mn(III) intermediate. In summary our results suggest
that in a biological environment MitoSOD and M40403 will
selectively decompose O2
,- by acting as both a SOD mimetic1240 Chemistry & Biology 19, 1237–1246, October 26, 2012 ª2012 Eand as an ascorbate/superoxide oxidoreductase catalyst,
thereby enhancing their ability to catalytically decompose O2
,-.
The overall kinetic scheme supported by these data and our
previous study (Maroz et al., 2008) is presented in Figure 3D.
To summarize, MitoSOD-catalyzed dismutation of O2
,- involves
an initial fast inner sphere oxidation of the macrocycle by O2
,-
(k1 = 1.57 ± 0.04 3 10
8 M1 s1 [pH 8.0]) to form an [MnIII(L-
TPP)ClnO2]
(2-n)+ intermediate that then undergoes a relatively
slow reduction (kcat) with further O2
,- to give a putative short-
lived [MnII(L-TPP)ClnO2]
(1-n)+ intermediate that rapidly decom-
poses to the parent [MnII(L-TPP)Cln]
(3-n)+ macrocycle (Maroz
et al., 2008). The essential observation is that MitoSOD has
similar SOD activity to M40403, demonstrating the structural
modification incorporated to facilitate transport into mitochon-
dria did not disrupt the desired catalytic activity. In addition,
MitoSOD and M40403 catalyze the reduction of O2
,- to H2O2
using electrons from ascorbate (Faulkner et al., 1994), as is
illustrated in Figure 3D. We conclude that MitoSOD should be
effective at selectively catalyzing the degradation of O2
,- within
mitochondria.
Stability, Charge, and Hydrophobicity of MitoSOD
To be biologically useful MitoSOD has to be stable. In 1 M HCl
MitoSOD rapidly dissociated to metal-free macrocycle and
Mn(II), as detected by positive ion electrospray mass spectrom-
etry (data not shown). The rates of MitoSOD dissociation from
pH 3.8 to 4.3 were modest and had a linear dependence on
[H+] (Figures S1A and S1B available online) (Aston et al., 2001),
as reported for M40403 (Salvemini et al., 1999). This gave kdislsevier Ltd All rights reserved
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Figure 4. Uptake of MitoSOD by Energized Mitochondria
(A) The ion-selective electrode response to ten sequential aliquots of 3 mM
MitoSOD at 30C was plotted versus log10[MitoSOD]. The straight line repre-
sents a linear function fitted to the data by least-squares regression analysis.
(B) Ion-selective electrode measurement of MitoSOD uptake by energized
mitochondria. Incubation medium supplemented with rotenone (4 mg ml1)
was added to the incubation chamber at 37C, and the electrode was then
calibrated by five sequential additions of 1 mM MitoSOD. Liver mitochondria
(2 mg protein ml1) were then added, followed by succinate (2 mM) and FCCP
(500 nM) where indicated.
(C) Time dependence of uptake of [3H]MitoSOD and [3H]M40403 by isolated
mitochondria. Rat liver mitochondria were incubated with 5 mM [3H]MitoSOD
or [3H]-M40403 at 25C and the uptake determined at various times. The data
are means of three separate experiments ± SEM. For the FCCP experiment,
500 nM FCCP was present.
(D) The effect of the mitochondrial membrane potential on the uptake of [3H]-
MitoSOD. Mitochondria were incubated with 800 nM MitoSOD and 1 mM
TPMP and supplemented with 1–16 mM malonate or FCCP (330 nM). Then
either 200 nM [3H]MitoSOD or 100 nM [3H]TPMP was added, and the ACR
values of [3H]MitoSOD or [3H]TPMP were determined in parallel. The data
are means of duplicate incubations of three separate experiments ± SEM. The
equation of the line is y = 1.727X + 415, R2 = 0.98.
See also Figure S1.
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MitoSODfor MitoSOD = 2.64 ± 0.113 102 M1 s1 at 18C, correspond-
ing to a half-life at pH 7.2 ofz13 years. This was corroborated by
incubating 150 mM MitoSOD at pH 8.0, which, by high-perfor-
mance liquid chromatography monitoring, showed that it was
stable for at least two weeks. In contrast, at pH 1.0 the half-life
is 3.8 min. Therefore, MitoSOD is stable under most biological
conditions but would dissociate rapidly in stomach acid.
For MitoSOD to act as a mitochondria-targeted antioxidant, it
must pass easily through phospholipid bilayers, which will
depend critically on its overall charge. The Mn(II) cation is bound
to the macrocycle (L-TPP) and 0, 1, or 2 chloro ligands, giving
three possible species: [MnII(L-TPP)]3+, [MnII(L-TPP)Cl]2+, orChemistry & Biology 19, 1237–1[MnII(L-TPP)Cl2]
+. The molar conductivity of MitoSOD in water
was 294 S cm2 mol1 at 20C, indicative of a 1:3 electrolyte (Fel-
tham and Hayter, 1964), indicating that both chloro ligands and
the TPP chloride counter anion dissociated to give [MnII(L-
TPP)]3+. However, when MitoSOD in 90% acetonitrile was
infused into a mass spectrometer, only species at m/z = 391
and 817 were detected, corresponding to [MnII(L-TPP)Cl]2+
and [MnII(L-TPP)Cl2]
+, and there was no peak at m/z = 249 as
expected for [MnII(L-TPP)]3+ (Figure S2A). This suggests that
under biological conditions of [Cl] (120 mM), the [MnII(L-
TPP)Cl]2+ and [MnII(L-TPP)Cl2]
+ forms will predominate. To
extend this we assessed the effect of [MitoSOD] on the potential
of an ion-selective electrode sensitive to TPP cations (Asin-
Cayuela et al., 2004). In 120 mM KCl, the electrode potential
was a linear function of log10[MitoSOD] with a slope of 29.7 ±
2.3mV/decade (Figure 4A), consistent with a Nernstian response
of the electrode to a dication. Together, these data suggest
that under biological conditions the predominant form of
MitoSOD is [MnII(L-TPP)Cl]2+ although [MnII(L-TPP)Cl2]
+ is also
likely to be present.
The uptake of lipophilic cations across phospholipid bilayers
is largely determined by the balance between their charge and
hydrophobicity (Ross et al., 2005). The charge raises the Born
energy for movement into the bilayer, and this is counteracted
by increasing hydrophobicity. Consequently, only relatively
hydrophobic TPP-conjugated compounds with low charge are
readily accumulated by mitochondria (Ross et al., 2005). Mito-
SOD was more lipophilic than the parent macrocycle M40403,
as shown by their octanol/PBS partition coefficients of 2.2 ±
0.03 and 0.63 ± 0.03, respectively (n = 3, means ± SD). The
MitoSOD partition coefficient is higher than that for many TPP
monocations, such as TPMP (partition coefficient = 0.33), which
is readily taken up intomitochondria, indicating that themonoca-
tion form of MitoSOD, [MnII(L-TPP)Cl2]
+, should be taken up by
energized mitochondria. The double charge on the dication
form of MitoSOD, [MnII(L-TPP)Cl]2+, raises its Born energy
considerably, and studies of bisTPP dications have shown that
they have to be more hydrophobic than the corresponding
monocation to be taken up by mitochondria (Ross et al., 2006,
2005). As lipophilic TPP dications with a partition coefficient
>0.8 are taken up (Ross et al., 2006), the doubly charged form
of MitoSOD, [MnII(L-TPP)Cl]2+, may be sufficiently hydrophobic
to pass through the mitochondrial inner membrane. However,
the form of MitoSOD present within the octanol phase may
be the moncation, and consequently it is not possible to
conclude from partition coefficient measurements alone that
the MitoSOD dication is sufficiently hydrophobic to cross a
biological membrane. We conclude that MitoSOD is stable to
dissociation under typical biological pH and exists predomi-
nantly as [MnII(L-TPP)Cl]2+ with small amounts of [MnII(L-TPP)
Cl2]
+. In addition, the monocation and possibly the dication
are sufficiently hydrophobic to be taken up across biological
membranes.
Uptake of MitoSOD by Energized Mitochondria
For MitoSOD to be an effective mitochondria-targeted SOD
mimetic, it must be selectively accumulated by mitochondria
in response to the membrane potential. To assess this, we
used an ion-selective electrode that is responsive to lipophilic246, October 26, 2012 ª2012 Elsevier Ltd All rights reserved 1241
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MitoSODTPP cations (Asin-Cayuela et al., 2004) and that responds to
MitoSOD (Figure 4A). The electrode response was calibrated
by additions of 1 to 5 mM MitoSOD, and then unenergized mito-
chondria were added, resulting in a lowering of the solution
concentration of MitoSOD (Figure 4B). The observation of exten-
sive binding of MitoSOD to the unenergized mitochondria is
consistent with the behavior of other hydrophobic TPP cations
(Asin-Cayuela et al., 2004). Addition of the respiratory substrate
succinate generated a membrane potential across the inner
membrane, leading to uptake of MitoSOD into the mitochondria,
as indicated by its loss from the incubation medium, and this
uptake was reversed when the uncoupler carbonyl cyanide-p-
trifluoromethoxyphenylhydrazone (FCCP) was added to dissi-
pate the membrane potential (Figure 4B). In this experiment
9 nmol of MitoSOD was bound to the unenergized mitochon-
dria, and on energization a further 4.5 nmol of MitoSOD was
taken up, corresponding to an intramitochondrial MitoSOD
concentration of 1.5 mM, assuming an intramitochondrial
volume of 0.5 ml mg protein1 (Brown and Brand, 1985). As the
external concentration of MitoSOD at this point was then
0.5 mM, this indicates an accumulation of approximately
3,000-fold, consistent with membrane potential-dependent
uptake and binding of MitoSOD within mitochondria.
To further assess MitoSOD uptake by mitochondria and
compare it with that of M40403, we next investigated the uptake
of [3H]MitoSOD and [3H]M40403. When [3H]MitoSOD was
incubated with energized mitochondria, there was rapid and
extensive uptake of MitoSOD into mitochondria that was stable
for up to 15 min and was decreased by incubation with the
uncoupler FCCP (Figure 4C). Conversely, when [3H]M40403
was incubatedwith energizedmitochondria, therewas negligible
accumulation of this macrocycle into the mitochondrial pellet
(Figure 4C). The far greater uptake of MitoSOD over M40403 is
consistent with its uptake into mitochondria in response to the
membrane potential. Overall, by considering the interaction
with unenergizedmitochondria (Figure 4B), with uncoupledmito-
chondria (Figure 4C), and the value of its partition coefficient, it
is clear that MitoSOD is extensively bound to unenergized
mitochondria by adsorption to membranes. To better distinguish
between simple binding and membrane potential-driven
accumulation into mitochondria, we expressed the uptake of
[3H]MitoSOD into the pellet as an accumulation ratio (ACR: mol
l1 in mitochondria/mol l1 in supernatant). This ACR of [3H]
MitoSOD was compared with that of [3H]TPMP in parallel exper-
iments over a range of mitochondrial membrane potentials set
by different concentrations of the respiratory inhibitor malonate
(Figure 4D) (Ross et al., 2008). As expected from Figures 4B
and 4C, it is evident that with uncoupled mitochondria, there is
extensive binding of MitoSOD, and as the membrane potential
increases there is an increase in ACR. The maximal ACR for
MitoSOD was found to be 1,300, whereas the ACR for TPMP
was 550 under comparable conditions. Furthermore, when
mitochondria were fully uncoupled with FCCP, the MitoSOD
ACR was still significant at 500. Together, these findings are
consistent with extensive nonspecific binding of the hydro-
phobic MitoSOD to mitochondria. The slope of the plot of the
ACR of MitoSOD against that of TPMP (Figure 4D) is greater
than one, indicating that within mitochondria there is more ex-
tensive binding of MitoSOD to the matrix face of the inner1242 Chemistry & Biology 19, 1237–1246, October 26, 2012 ª2012 Emembrane than for TPMP, as expected from its greater hydro-
phobicity (partition coefficient: MitoSOD, 2.2; TPMP, 0.33).
It is well established that the uptake of TPMP reflects themito-
chondrial membrane potential and is satisfactorily described
by the Nernst equation for a monocation. The uptake of
MitoSOD (Figure 4D) is about twice that of TPMP. However, if
MitoSOD crosses the membrane as a dication then, from the
Nernst equation, its uptake would be expected to be orders of
magnitude greater than that of TPMP (Ross et al., 2006). Further-
more, the ACR for MitoSOD is a linear function of that for TPMP,
consistent with the uptake of MitoSOD as a monocation. Earlier
we showed that the dication form of MitoSOD predominates
in biological solutions. For a dication to be taken up across
a phospholipid bilayer the high Born energy for transport due
to the double charge must be balanced by elevated hydropho-
bicity. The octanol/PBS partition coefficient for MitoSOD was,
by comparision with other lipohilic dications, sufficient for it to
be taken up into mitochondria. However, a limitation to this
comparision is that the form of MitoSOD that partitions into the
octanol phase may be the monocation, in which case the dica-
tion form of MitoSOD may be too hydrophilic to pass through
a phospholipid bilayer. This possibility, in conjunction with the
data from Figure 4, lead us to conclude that MitoSOD is taken
up by mitochondria in response to the membrane potential
and, even though the dominant form of MitoSOD in solution is
a dication, the monocation is likely to be the major form passing
through the membrane bilayer.
For MitoSOD to be an effective SOD mimetic within mito-
chondria, it is important that it is taken up as the intact Mn(II)
macrocycle. The apo form of MitoSOD, in which Mn has been
removed by acid treatment, was found to be readily taken up
by energized mitochondria (data not shown). Consequently,
the uptake of MitoSOD as seen in Figure 4 could be explained
by prior dissociation of Mn from MitoSOD, followed by uptake
of apo-MitoSOD. To determine whether MitoSOD was accu-
mulated intact, we measured, by inductively coupled plasma
mass spectrometry, the extent of Mn uptake into mitochondria
during incubations with MitoSOD. Incubation with 5 mM
MitoSOD led to the rapid uptake of2.5–3.5 nmolMn (Figure 5A),
with similar kinetics and extent of uptake as seen for MitoSOD
itself (Figure 4). To see if it was possible for apo-MitoSOD to
be taken up by mitochondria and then incorporate Mn to form
MitoSOD in situ, we incubated apo-MitoSOD with MnCl2 and
found no observable Mn incorporation to give MitoSOD, as
assessed by mass spectrometry (Figure S2B). Incubation of
apo-MitoSOD with mitochondria did not lead to MitoSOD
assembly (data not shown), and incubation of apo-MitoSOD
and MnCl2 with mitochondria did not lead to uptake of Mn into
mitochondria (Figure 5A). Therefore, we conclude that MitoSOD
is taken up into mitochondria as an intact complex and the
uptake of apo-MitoSOD alone does not lead to the assembly
of MitoSOD within the mitochondrial matrix.
MitoSOD Protects Mitochondrial Aconitase
from Superoxide Damage
To assess the ability of MitoSOD to detoxify O2
,- within mito-
chondria, we used the redox cycler paraquat to induce O2
,-
formation in isolated heart mitochondria and monitored the
O2
,--dependent inactivation of the intramitochondrial enzymelsevier Ltd All rights reserved
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Figure 5. MitoSOD Increases Mitochondrial Mn Uptake and
Decreases Aconitase Inactivation
Rat liver mitochondria (1 mg protein ml1) were incubated in 0.5 ml incubation
medium supplemented with 10 mM succinate, 8 mg ml1 rotenone at 37C for
the indicated times with 5 mM MitoSOD, no additions, 5 mM MnCl2, or 1 mM
apo-MitoSOD + 5 mM MnCl2. Then the mitochondria were pelleted, and the
concentration of Mn in the pellets was determined by inductively coupled
plasma (ICP) analysis. Data are means ± SD of quadruplicate determinations.
(B) Rat heart mitochondria (2 mg protein ml1) were incubated in incubation
medium (600–800 ml) containing glutamate/malate (10 mM) and bovine serum
albumin (5% w/v), with or without paraquat (500 mM) or MitoSOD (5 mM) or
M40403 (5 mM), at 37C for the indicated times. Samples (100 ml), taken
immediately before paraquat addition and at the indicated times were
snap-frozen on dry ice and assessed for aconitase activity. Aconitase activity
is expressed as a percentage of the activity immediately before paraquat
addition. Data correspond to the means ± SD of three independent experi-
ments.
(C) Mitochondria were incubated and processed as in (B) for 6 min with or
without paraquat (500 mM), MitoSOD (5 mM), or M40403 (5 mM). Statistical
significance was calculated by a two-tailed, paired Student’s t test.
See also Figure S2.
Chemistry & Biology
MitoSOD
Chemistry & Biology 19, 1237–1aconitase, which is particularly sensitive to O2
,- (Cocheme´ and
Murphy, 2008). Paraquat decreased the activity of mitochondrial
aconitase to 18% of control, and addition of MitoSOD partially
protected aconitase from this damage (Figures 5B and 5C). In
contrast, M40403 was ineffective, presumably because of its
lack of uptake by mitochondria (Figure 5C). Although the extent
of protection by MitoSOD is modest, this is expected because
the rate constant of MitoSOD-catalyzed O2
,- dismutation (5 3
106 M1 s1 at pH 8.0, 22C) is 400-fold lower than kcat for
the mitochondrial enzyme MnSOD (2 3 109 M1 s1 at 25C;
Bull et al., 1991). However, the large amount of MitoSOD taken
up by mitochondria in response to the membrane potential
(1.5 mM) significantly increases the O2,- defense capacity,
although as the concentration of MnSOD in the mitochondrial
matrix is 10–20 mM, the accumulated MitoSOD provides at
most 20%–30% of the SOD activity in the mitochondrial matrix
under these conditions. Higher concentrations of MitoSOD
provided no further protection because at higher concentrations
TPP cations start to affect the membrane potential, thereby
limiting further accumulation.
SIGNIFICANCE
Antioxidants targeted to mitochondria by conjugation to
lipophilic cations have proven useful as tools for investi-
gating oxidative damage and redox signaling, and as poten-
tial therapies for diseases involving mitochondrial oxidative
damage (Murphy and Smith, 2007, 2010). Although some
mitochondria-targeted antioxidants can react with O2
,-,
they are not selective. Consequently, it is not possible to
infer if their action is due to depleting O2
,- or to some other
antioxidant reaction. We have resolved this issue by invent-
ing a mitochondria-targeted antioxidant that is selective for
O2
,-. This was achieved by conjugating the core function-
ality of the Mn(II) macrocycle SOD mimetic M40403 to the
mitochondria-targeting lipophilic cation TPP. The resultant
compound, MitoSOD, was a very effective catalytic SOD
mimetic and also had catalytic O2
,- reductase activity in
the presence of the biological reductant ascorbate. The
rate constant of MitoSOD-catalyzed O2
,- dismutation (5 3
106 M–1 s–1 at pH 8.0, 22C) is lower than kcat for the mito-
chondrial enzyme MnSOD (2 3 109 M–1 s–1 at 25C; Bull
et al., 1991). However, the large amount of MitoSOD taken
up by mitochondria in response to the membrane potential
significantly increases the O2
,- defense capacity within
mitochondria above that provided by the endogenous
MnSOD enzyme alone, indicating that this is a viable antiox-
idant strategy and that developing analogs of MitoSOD
with greater rates of O2
,- dismutation is the best path to
development of future SOD mimetics. To our knowledge,
MitoSOD constitutes the first example of a selective macro-
cyclicMn(II) SODmimetic that is taken up intomitochondria,
driven by the membrane potential, and exhibits a protective
effect against O2
,- within mitochondria. This work estab-
lishes the baseline parameters for the rational development
of bioactive mitochondria-targeted SOD mimetics, as well
as other mitochondria-targeted macrocycle and metal-
dependent moieties, with potential for pharmaceutical
application.246, October 26, 2012 ª2012 Elsevier Ltd All rights reserved 1243
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Synthetic Chemistry
The target compounds MitoSOD (1) and M40403 (2) were obtained by Mn(II)
template cyclization of the tetraamine 3 and 4 or 2,6-pyridinedialdehyde,
respectively, followed by in situ borohydride reduction of the intermediate
Schiff-base macrocycle (Figure 1A). General synthetic methods and details
of syntheses are given in the Supplemental Experimental Procedures.
X-Ray Crystallography
X-ray data were collected by Assoc. Prof. C.E.F. Rickard, The University of
Auckland, New Zealand, on a Bruker SMART diffractometer using graphite-
monochromated Mo-Ka radiation (l = 0.71073 A˚). MitoSOD crystallized in
the chiral monoclinic space group P21 with one molecule of coordinated
water and two half occupancy noncoordinated molecules of ethanol per
MnLCl3, that is, as [MnLCl(OH2)]Cl2$EtOH. The data were corrected for
Lorentz and polarization effects, and a semiempirical absorption correction
(SADABS) was applied. The structure was solved by direct methods
(SHELXS-97) (Sheldrick, 1990, 1997) and refined using SHELXL-97 (Sheldrick
and Schneider, 1997). All nonhydrogen atoms were made anisotropic.
Hydrogen atoms were inserted at calculated positions and rode on the atoms
to which they are attached, except for those on N2, N3, N4, N5, and O1,
which were located from difference maps and fixed (AFIX 01). The two half
occupancy EtOH solvent molecules are both well behaved. One of the two
noncoordinating chloride ions is modeled as disordered over two sites as
0.85:0.15 Cl2:Cl20 (an attempt to model this as a Cl:Br disorder resulted in
0.9:0.1 occupancy; this option, of the presence of a trace of Br, cannot be
excluded although it was not employed here). Mn(II) is coordinated by the
five N atoms of the macrocycle in a near-planar arrangement, as evident
from the sum of the five N-Mn-N chelate angles (363). A chloride ion and
water molecule are also coordinated to Mn(II), with a ClMn-O angle of
176.8; the geometry of the coordination sphere is best described as pentag-
onal bipyramidal. The alternating axial disposition of the cyclohexyl methine
hydrogens confirmed the stereochemistry of the four chiral centers of the
macrocycle. Despite the existence of M40403 being known for at least a
decade, its X-ray structure remains unreported. An attempt by us to prepare
crystals of M40403 resulted in crystal twinning, and an X-ray structure was
unable to be obtained. Hence, the MitoSOD structure was compared to the
X-ray structure of a pentagonal bipyramidal polymorph of M40401, an active
1,1’-(pyridine-2,6-diyl)diethanamine analog of M40403 (Aston et al., 2001).
The MitoSOD and M40401 structures showed similar Mn-N bond lengths
and N-Mn-N chelate angles.
Pulse Radiolysis
The 4 MeV linear accelerator (LINAC) of The University of Auckland,
New Zealand, was used to irradiate sample solutions contained in a quartz
cuvette. The LINAC has been adapted to produce variable amounts of
radiation (0–100 Gy in 1.5 ms) to the sample. Dosimetry was carried out
using aerated KSCN solution assuming the (SCN)2
,- radical produced has
a radiation chemical yield (G) of 0.29 mM Gy1 and an extinction coefficient
of 7,580 M1 cm1 at 475 nm (Schuler et al., 1980). Changes in absorbance
were measured using a PC-controlled custom-built optical detection system
(Anderson et al., 1997). All experiments were performed at 22C ± 1C.
The radiolysis of water with high-energy electrons produces both primary
radical species and products as shown in Equation (1). The G-values of the
different species (in mM Gy1) are shown in parentheses.
H2O,e

aqð0:28Þ+ $OHð0:28Þ+ $Hð0:055Þ+H2ð0:04Þ+H2O2ð0:07Þ+H3O+ ð0:28Þ
(1)
Quantitative amounts of O2
,- were produced in aerated solutions containing
sodium formate (10 mM), phosphate buffer (10 mM [pH 7.4 or 8.0]), and EDTA
(0.1 mM). Under these conditions, all the primary radical species are quickly
converted into O2
,-, as described by Equations (2)–(7), resulting in a yield
of O2
,- of 0.62 mM Gy1 by the end of the pulse (Bielski et al., 1985; Ilan and
Rabani, 1976).
O2 + e

aq / O
$
2 k = 1:9310
10 M1 s1; (2)1244 Chemistry & Biology 19, 1237–1246, October 26, 2012 ª2012 EO2 +H
$ / HO$2 k = 1:23 10
10 M1 s1; (3)HO2$ ! H
+ +O$2 ; (4)
HCO2 +HO$ / CO
$
2 +H2O k = 3:23 10
9 M1 s1; (5)
HCO2 +H$ / CO
$
2 +H2 k = 2:1310
8 M1 s1; (6)
O2 +CO
$
2 / O
$
2 +CO2 k = 4:23 10
9 M1 s1: (7)
The decay in the optical absorbance due to O2
,-, for various radiation doses,
was monitored at 270 nm, and the first half-lives were obtained directly from
the absorbance traces.
Determination of SOD Activity
For Figures 3A and 3B, a mixture of acetylated ferricytochrome c (25 mM) in
potassium phosphate (50 mM) and EDTA (100 mM) at pH 7.8 was supple-
mented with hypoxanthine (50 mM), held at 25C in a 1 ml cuvette, and the
absorbance at 550 nm was monitored (Loschen et al., 1974). After 30 s
incubation, O2
,- production was initiated by addition of xanthine oxidase
(XO, 0.2 U ml1) to give an O2
,- generation rate of6 mMmin1, and then after
a further 90 s the test compounds were added from a DMSO stock solution.
The rate of cytochrome c reduction at 550 nm was recorded for a further
3 min. Monitoring the formation of uric acid at 295 nm confirmed that MitoSOD
up to at least 10 mM did not inhibit XO activity. Demetallation of MitoSOD by
treatment with acid gave a metal-free residue that had no SOD activity. The
comparison of the specific SOD activity for Cu,ZnSOD, MitoSOD, and
M40403 was assessed by the WST-1 assay as described (Peskin and Winter-
bourn, 2000). For Figure 3C, ascorbate oxidation and cytochrome c reduction
were measured at 22C in 50 mM phosphate buffer (pH 7.4) containing 50 mM
DTPA and 5 mg ml1 catalase. A flux of O2
,- was generated by addition of XO
(0.1 U ml1 to give a O2,- generation rate of 2 mM min1) and acetaldehyde
(10 mM). Cu,ZnSOD (60 nM), or various concentrations of M40403 and
MitoSOD, was added to this. Then either cytochrome c (20 mM) was added
and its rate of reduction was monitored at 550 nm, or ascorbate (30 mM)
was added and its rate of oxidation was monitored at 266 nm. Data are
means ± ranges for 2–3 determinations. The oxidation rate of ascorbate alone,
which was 2% of the O2,--dependent reaction, was subtracted.
Uptake of MitoSOD by Mitochondria
An ion-selective electrode was prepared that responds to the triphenylphos-
phonium (TPP) moiety (Asin-Cayuela et al., 2004) and inserted into a stirred
solution of incubation medium (120 mM KCl, 10 mM HEPES [pH 7.2], and
1 mM EGTA). The uptake of [3H]MitoSOD and [3H]M40403 by isolated rat liver
mitochondria (1 mg protein ml1) was determined by suspension in Incubation
Medium supplemented with 10 mM succinate, 8 mg ml1 rotenone, 4 mM
MitoSOD or M40403, and 1 mM [3H]MitoSOD (28 Ci mol1) or [3H]-M40403
(13 Ci mol1) at 25C. The uptake of [3H]MitoSOD and [3H]M40403 was deter-
mined at various times by isolating the mitochondria by centrifugation and
then determining the amount of [3H]macrocycle in the mitochondrial pellet by
scintillation counting and using the specific activity of the starting solution to
calculate the amount associated with the mitochondria (Kelso et al., 2001;
Smith et al., 1999, 2004). The data are means of three separate experiments ±
SEM. For the FCCP experiment, 500 nM FCCP was present. To determine the
effect of the mitochondrial membrane potential on the uptake of [3H]-MitoSOD
rat livermitochondria (1mg proteinml1) were incubated in incubationmedium
containing 10mMsuccinate, 8 mgml1 rotenone, 100 mgml1 nigericin, 800 nM
MitoSOD, 1 mM TPMP, and 1–16 mM malonate, or to measure the uptake of
3H-labeled compounds in the complete absence of a membrane potential,
FCCP (330 nM) was added to the incubation medium. These were supple-
mented with either 200 nM [3H]MitoSOD (28 Ci mol1) or 100 nM [3H]TPMP
(500 Ci mol1) for 3 min at 25C. The ACR of [3H]MitoSOD or [3H]TPMP was
determined at various times in parallel to enable the ACR for the two com-
pounds to be determined under identical conditions by isolating the mito-
chondria by centrifugation and then determining the amount of [3H]MitoSOD
or [3H]TPMP in the mitochondrial pellet and in the supernatant by scintillation
counting and taking the mitochondrial volume as 0.5 ml mg protein1.lsevier Ltd All rights reserved
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Aliquots (10 ml) of the snap-frozen mitochondrial incubtions samples were
incubated in assay buffer (190 ml) comprising Tris-HCl (50 mM [pH 7.4]),
MnCl2 (0.6 mM), sodium citrate (5 mM [pH 7.0]), NADP
+ (0.2 mM), Triton
X-100 (0.1% v/v), and isocitrate dehydrogenase (0.4 U ml1) in quintuplicate
at 30C in a 96-well plate, and the appearance of NADPH (ε340 = 6.22 3 10
3
M1 cm1) was monitored over 10 min at 340 nm (Cocheme´ and Murphy,
2008).SUPPLEMENTAL INFORMATION
Supplemental Information includes two figures, three tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.chembiol.2012.08.005.
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